The recent advances in the discovery of antifungal agents, including fosmanogepix, ibrexafungerp, and rezafungin, have been a significant trend towards novel antifungal agents with new targets, better pharmacokinetics, and activity against resistant isolates.
← all excerpts
Pharmacological advances in <i>Candida auris</i>: emerging antifungal mechanisms and next-generation therapeutic strategies.
1
—
—